Deferiprone (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Deferiprone" in Italian language version.

refsWebsite

Global rank Italian rank

5nih.gov

4^th place

9^th place

3doi.org

2^nd place

7^th place

2web.archive.org

1^st place

1broadinstitute.org

low place

1torrinomedica.it

low place

2,002^nd place

1ferriprox.com

low place

1wkhealth.com

low place

7,876^th place

broadinstitute.org

chembank.broadinstitute.org

ChemBank - Molecule Display, su chembank.broadinstitute.org. URL consultato il 9 luglio 2010.

doi.org

dx.doi.org

McLeod C, Fleeman N, Kirkham J, et al., Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation, in Health Technology Assessment (Winchester, England), vol. 13, n. 1, gennaio 2009, pp. iii–iv, ix–xi, 1–121, DOI:10.3310/hta13010, PMID 19068191. URL consultato il 9 luglio 2010 (archiviato dall'url originale il 26 luglio 2010).
Roberts DJ, Brunskill SJ, Doree C, Williams S, Howard J, Hyde CJ, Oral deferiprone for iron chelation in people with thalassaemia, in Cochrane Database of Systematic Reviews (Online), n. 3, 2007, pp. CD004839, DOI:10.1002/14651858.CD004839.pub2, PMID 17636775. URL consultato il 9 luglio 2010.
Roberts DJ, Rees D, Howard J, Hyde C, Alderson P, Brunskill S, Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia, in Cochrane Database of Systematic Reviews (Online), n. 4, 2005, pp. CD004450, DOI:10.1002/14651858.CD004450.pub2, PMID 16235363. URL consultato il 9 luglio 2010.

ferriprox.com

Ferriprox (deferiprone), su ferriprox.com. URL consultato il 9 luglio 2010.

nih.gov

ncbi.nlm.nih.gov

Kontoghiorghes GJ, Neocleous K, Kolnagou A, Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine ^{[collegamento interrotto]}, in Drug Safety : an International Journal of Medical Toxicology and Drug Experience, vol. 26, n. 8, 2003, pp. 553–84, PMID 12825969. URL consultato il 9 luglio 2010.
McLeod C, Fleeman N, Kirkham J, et al., Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation, in Health Technology Assessment (Winchester, England), vol. 13, n. 1, gennaio 2009, pp. iii–iv, ix–xi, 1–121, DOI:10.3310/hta13010, PMID 19068191. URL consultato il 9 luglio 2010 (archiviato dall'url originale il 26 luglio 2010).
Roberts DJ, Brunskill SJ, Doree C, Williams S, Howard J, Hyde CJ, Oral deferiprone for iron chelation in people with thalassaemia, in Cochrane Database of Systematic Reviews (Online), n. 3, 2007, pp. CD004839, DOI:10.1002/14651858.CD004839.pub2, PMID 17636775. URL consultato il 9 luglio 2010.
Roberts DJ, Rees D, Howard J, Hyde C, Alderson P, Brunskill S, Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia, in Cochrane Database of Systematic Reviews (Online), n. 4, 2005, pp. CD004450, DOI:10.1002/14651858.CD004450.pub2, PMID 16235363. URL consultato il 9 luglio 2010.
Addis A, Loebstein R, Koren G, Einarson TR, Meta-analytic review of the clinical effectiveness of oral deferiprone (L1)., in Eur J Clin Pharmacol, vol. 55, n. 1, 1999, pp. 1-6, PMID 10206077.

torrinomedica.it

FERRIPROX, su torrinomedica.it. URL consultato il 9 luglio 2010.

web.archive.org

www.ferriprox.com (PDF), su ferriprox.com. URL consultato il 9 luglio 2010 (archiviato dall'url originale l'8 novembre 2011).
McLeod C, Fleeman N, Kirkham J, et al., Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation, in Health Technology Assessment (Winchester, England), vol. 13, n. 1, gennaio 2009, pp. iii–iv, ix–xi, 1–121, DOI:10.3310/hta13010, PMID 19068191. URL consultato il 9 luglio 2010 (archiviato dall'url originale il 26 luglio 2010).

wkhealth.com

content.wkhealth.com

Kontoghiorghes GJ, Neocleous K, Kolnagou A, Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine ^{[collegamento interrotto]}, in Drug Safety : an International Journal of Medical Toxicology and Drug Experience, vol. 26, n. 8, 2003, pp. 553–84, PMID 12825969. URL consultato il 9 luglio 2010.